| Agarikon | 8 capsule | RCT of Fomitopsis Officinalis and Trametes Versicolor to Treat COVID-19 | COVID-19 | 54 | Completed |
| Antrodia | 100 mg | Evaluate Efficacy and Safety/Tolerability Profiles of Antroquinonol in Acute Myeloid L | Leukemia, Myeloid, Acute | 12 | Completed |
| Antrodia | 100mg | Determine MTD and to Evaluate pk, Safety/Tolerability and Efficacy Profiles of Hocena® | Non-small Cell Lung Cancer | 13 | Completed |
| Antrodia | 100mg | A Phase II, Placebo-controlled Trial Evaluating the Efficacy of Antroquinonol in Patie | Atopic Dermatitis | 14 | Terminated |
| Antrodia | 100mg per day | A Phase II, Placebo-controlled Trial Evaluating the Efficacy of Antroquinonol in Patie | Atopic Dermatitis | 14 | Terminated |
| Antrodia | 2 capsule | Effects of Antrodia Cinnamomea on the Hepatoma Patients After Transcatheter Hepatic Ar | Hepatocellular Carcinoma, Transarterial Chem | 23 | Terminated |
| Antrodia | 200 mg | Efficacy, Safety and Pharmacokinetics Study of Antroquinonol to Treat NSCLC | Non-small Cell Lung Cancer Stage IV | 31 | Completed |
| Antrodia | 200mg | Evaluate Efficacy and Safety/Tolerability Profiles of Antroquinonol in Acute Myeloid L | Leukemia, Myeloid, Acute | 12 | Completed |
| Antrodia | 200mg | Determine MTD and to Evaluate pk, Safety/Tolerability and Efficacy Profiles of Hocena® | Non-small Cell Lung Cancer | 13 | Completed |
| Antrodia | 300mg | Evaluate Efficacy and Safety/Tolerability Profiles of Antroquinonol in Acute Myeloid L | Leukemia, Myeloid, Acute | 12 | Completed |
| Antrodia | 300mg | Determine MTD and to Evaluate pk, Safety/Tolerability and Efficacy Profiles of Hocena® | Non-small Cell Lung Cancer | 13 | Completed |
| Antrodia | 420 mg | Anti-hypertensive Effect of Mycelia of Antrodia Cinnamomea | Hypertension | 41 | Completed |
| Antrodia | 450, 600 mg/day | Determine MTD and to Evaluate pk, Safety/Tolerability and Efficacy Profiles of Hocena® | Non-small Cell Lung Cancer | 13 | Completed |
| Antrodia | 450mg | Determine MTD and to Evaluate pk, Safety/Tolerability and Efficacy Profiles of Hocena® | Non-small Cell Lung Cancer | 13 | Completed |
| Antrodia | 50 mg | A Trial of Antroquinonol in Patients With Atopic Dermatitis | Atopic Dermatitis | 14 | Completed |
| Antrodia | 50 mg | A Randomized, Double-Blind Trial of Antroquinonol in Patients With Chronic Hepatitis B | HBV | 60 | Completed |
| Antrodia | 50 mg | Determine MTD and to Evaluate pk, Safety/Tolerability and Efficacy Profiles of Hocena® | Non-small Cell Lung Cancer | 13 | Completed |
| Antrodia | 50 mg | Trial of Antroquinonol in Patients With Hypercholesterolemia and Hyperlipidemia | Hyperlipidemias | 120 | Completed |
| Antrodia | 500mg | A Multiple-Dose Research Study on Safety Evaluation of the GD Antrodia Camphorata in 3 | Healthy | 31 | Completed |
| Antrodia | 50mg | A Phase II, Placebo-controlled Trial Evaluating the Efficacy of Antroquinonol in Patie | Atopic Dermatitis | 14 | Terminated |
| Antrodia | 50mg per day | A Phase II, Placebo-controlled Trial Evaluating the Efficacy of Antroquinonol in Patie | Atopic Dermatitis | 14 | Terminated |
| Antrodia | 600 mg/day | Effectiveness of Antrodia Cinnamomea Mycelia on Improving Immune Response in Subhealth | Fatigue Syndrome, Chronic, Cold | 25 | Completed |
| Button mushroom | 10 capsule | Agaricus Bisporus and Influenza Vaccination Response | Immune Response | 88 | Completed |
| Button mushroom | 10 g | White Button Mushroom Extract in Treating Patients With Recurrent Prostate Cancer Afte | Prostate Cancer | 36 | Completed |
| Button mushroom | 10 g/day | White Button Mushroom Extract in Preventing the Recurrence of Breast Cancer in Postmen | Breast Cancer, Cancer Survivor | 16 | Completed |
| Button mushroom | 12 g | White Button Mushroom Extract in Treating Patients With Recurrent Prostate Cancer Afte | Prostate Cancer | 36 | Completed |
| Button mushroom | 13 g/day | White Button Mushroom Extract in Preventing the Recurrence of Breast Cancer in Postmen | Breast Cancer, Cancer Survivor | 16 | Completed |
| Button mushroom | 14 g | White Button Mushroom Extract in Treating Patients With Recurrent Prostate Cancer Afte | Prostate Cancer | 36 | Completed |
| Button mushroom | 2.0 mg | Long-term Safety and Performance of KiOmedine CM-Chitosan Supplementation in Advanced | Osteoarthritis, Knee | 104 | Unknown |
| Button mushroom | 4 g | White Button Mushroom Extract in Treating Patients With Recurrent Prostate Cancer Afte | Prostate Cancer | 36 | Completed |
| Button mushroom | 5 g | Agaricus Bisporus and Influenza Vaccination Response | Immune Response | 88 | Completed |
| Button mushroom | 5 g/day | White Button Mushroom Extract in Preventing the Recurrence of Breast Cancer in Postmen | Breast Cancer, Cancer Survivor | 16 | Completed |
| Button mushroom | 500 mg | Agaricus Bisporus and Influenza Vaccination Response | Immune Response | 88 | Completed |
| Button mushroom | 6 g | White Button Mushroom Extract in Treating Patients With Recurrent Prostate Cancer Afte | Prostate Cancer | 36 | Completed |
| Button mushroom | 8 g | White Button Mushroom Extract in Treating Patients With Recurrent Prostate Cancer Afte | Prostate Cancer | 36 | Completed |
| Button mushroom | 8 g/day | White Button Mushroom Extract in Preventing the Recurrence of Breast Cancer in Postmen | Breast Cancer, Cancer Survivor | 16 | Completed |
| Button mushroom | 8.0 mg | Long-term Safety and Performance of KiOmedine CM-Chitosan Supplementation in Advanced | Osteoarthritis, Knee | 104 | Unknown |
| Cauliflower fungus | 1g/day | Efficacy and Safety of Cauliflower Mushroom Extract on Promotion of Immunity | Immunity | 60 | Completed |
| Chaga | 1mg | Mood and Cognitive Effects of Psilocybin in Healthy Participants | Mood Disturbance, Mood Change | — | Withdrawn |
| Chaga | 2 capsule | Rapid Response of Stem Cells and Immune Cells for Efficacy | Stem Cell Surveillance | 24 | Recruiting |
| Cordyceps | 0.619g | Efficacy Study of Herbal Formula CUF2 to Treat Childhood Asthma | Asthma | 90 | Completed |
| Cordyceps | 0.76 g | Efficacy and Safety of Cordyceps Sinensis Mycelium Culture Extract(Paecilomyces Hepial | Immunity | 90 | Completed |
| Cordyceps | 1 g | A Trial to Study the Effects of Ginseng and Cordyceps on Aerobic Capacity, Lactate Kin | Healthy Subjects With Low Energy Levels | 75 | Recruiting |
| Cordyceps | 1.15 g | Efficacy and Safety of Cordyceps Sinensis Mycelium Culture Extract(Paecilomyces Hepial | Immunity | 90 | Completed |
| Cordyceps | 1.68 g | The Efficacy and Safety of Cordyceps Sinensis Mycelium Culture Extract(Paecilomyces He | Immunity | 80 | Completed |
| Cordyceps | 100 mg | Effect of HIFAS MENOPAUSE on Quality of Life in Postmenopausal Women | Menopause, Menopausal Symptoms | 20 | Completed |
| Cordyceps | 10g | A Clinical Evaluation of Baofeikang Granule in Combined Pulmonary Fibrosis and Emphyse | Combined Pulmonary Fibrosis and Emphysema | 120 | Unknown |
| Cordyceps | 120 mg | Vitamin C Plus Cordyceps to Chemotherapy Related Anemia in Pancreatic Cancer | Pancreatic Cancer | 50 | Recruiting |
| Cordyceps | 12g | A Clinical Evaluation of Baofeikang Granule in Combined Pulmonary Fibrosis and Emphyse | Combined Pulmonary Fibrosis and Emphysema | 120 | Unknown |
| Cordyceps | 15g | A Clinical Evaluation of Baofeikang Granule in Combined Pulmonary Fibrosis and Emphyse | Combined Pulmonary Fibrosis and Emphysema | 120 | Unknown |
| Cordyceps | 2 g/day | Vitamin C Plus Cordyceps to Chemotherapy Related Anemia in Pancreatic Cancer | Pancreatic Cancer | 50 | Recruiting |
| Cordyceps | 2 g/day | Vitamin C Plus Cordyceps to Quality of Life in Patients With Terminal Stage Pancreatic | Pancreatic Cancer | 50 | Recruiting |
| Cordyceps | 2,000 mg | Effect of Cordyceps Supplementation Timing on Physiological Responses and Aerobic Adap | Exercise Recovery, Exercise-induced Muscle D | 30 | Completed |
| Cordyceps | 200 mg | Metabolic Effects of an Ophiocordyceps Sinensis- and CoQ10-Based Formulation in Mild-t | Hypercholesterolemia, Lipid Metabolism Disor | 140 | Not yet recruiting |
| Cordyceps | 200 mg | Effect of Cordyceps Supplementation Timing on Physiological Responses and Aerobic Adap | Exercise Recovery, Exercise-induced Muscle D | 30 | Completed |
| Cordyceps | 200ml | The Efficacy and Safety of a Chinese Herbal Medicine for Long COVID Associated Fatigue | Long COVID | 152 | Unknown |
| Cordyceps | 225 mg | Effects of Herbal Supplements on Endurance Exercise Performance | Exercise Performance | 13 | Completed |
| Cordyceps | 240 mg | Effect of HIFAS MENOPAUSE on Quality of Life in Postmenopausal Women | Menopause, Menopausal Symptoms | 20 | Completed |
| Cordyceps | 250 mg | Effects of Herbal Supplements on Endurance Exercise Performance | Exercise Performance | 13 | Completed |
| Cordyceps | 280 mg | Effect of HIFAS MENOPAUSE on Quality of Life in Postmenopausal Women | Menopause, Menopausal Symptoms | 20 | Completed |
| Cordyceps | 300 mg/day | Vitamin C Plus Cordyceps to Chemotherapy Related Anemia in Pancreatic Cancer | Pancreatic Cancer | 50 | Recruiting |
| Cordyceps | 300 mg/day | Vitamin C Plus Cordyceps to Quality of Life in Patients With Terminal Stage Pancreatic | Pancreatic Cancer | 50 | Recruiting |
| Cordyceps | 30g | A Clinical Evaluation of Baofeikang Granule in Combined Pulmonary Fibrosis and Emphyse | Combined Pulmonary Fibrosis and Emphysema | 120 | Unknown |
| Cordyceps | 4 capsule | Prevention of Recurrence With Cordyceps Sinensis in Mycobacterium Avium Complex Pulmon | Mycobacterium Avium Complex Pulmonary Diseas | 300 | Recruiting |
| Cordyceps | 50 mg | Metabolic Effects of an Ophiocordyceps Sinensis- and CoQ10-Based Formulation in Mild-t | Hypercholesterolemia, Lipid Metabolism Disor | 140 | Not yet recruiting |
| Cordyceps | 500 mg | The Combined Effects of Cordyceps and Fartlek Training on Muscle Recovery and Bone Hea | Muscle Damage, Athletic Performance | 22 | Completed |
| Cordyceps | 500mg | Evaluation of the Protective Effects of Cordyceps Cicadae on Visual Function and Anti- | Visual Acuity, Accommodation | 12 | Active not recruiting |
| Cordyceps | 500mg | Exploring the Eye Care Benefits of Cordyceps Cicadae Across Different Age Groups | Visual Acuity, Accommodation | 200 | Active not recruiting |
| Cordyceps | 500mg/ day | To Study the Effects of Cordyceps Cicadae on Vision Care | Myopia | 60 | Completed |
| Lion's mane | 100 mg | Effect of HIFAS MENOPAUSE on Quality of Life in Postmenopausal Women | Menopause, Menopausal Symptoms | 20 | Completed |
| Lion's mane | 150 mg | Lifestyle Changes, Mushroom Supplementation, and Bupropion to Reduce Adiposity and Car | Cardiometabolic Syndrome, Obesity and Cardio | 250 | Not yet recruiting |
| Lion's mane | 180 mg | Effects of L-Theanine and Hericium Erinaceus Gummies on Psychological, Cognitive, and | Psychological Stress, Anxiety | 67 | Completed |
| Lion's mane | 1ml per day | The Impact of Supplementation With Hericium Erinaceus (Lion's Mane) Extract on Cogniti | Attention, Memory | 85 | Completed |
| Lion's mane | 20,000 mg | The Impact of Supplementation With Hericium Erinaceus (Lion's Mane) Extract on Cogniti | Attention, Memory | 85 | Completed |
| Lion's mane | 240 mg | Effect of HIFAS MENOPAUSE on Quality of Life in Postmenopausal Women | Menopause, Menopausal Symptoms | 20 | Completed |
| Lion's mane | 280 mg | Effect of HIFAS MENOPAUSE on Quality of Life in Postmenopausal Women | Menopause, Menopausal Symptoms | 20 | Completed |
| Lion's mane | 30 mg | Effects of L-Theanine and Hericium Erinaceus Gummies on Psychological, Cognitive, and | Psychological Stress, Anxiety | 67 | Completed |
| Lion's mane | 300 mg | Effects of L-Theanine and Hericium Erinaceus Gummies on Psychological, Cognitive, and | Psychological Stress, Anxiety | 67 | Completed |
| Lion's mane | 430 mg/kg | Effect of Hericium Erinaceus on Clinical Patients With Hearing Impairment | Tinnitus | 80 | Unknown |
| Lion's mane | 50 mg | Effects of L-Theanine and Hericium Erinaceus Gummies on Psychological, Cognitive, and | Psychological Stress, Anxiety | 67 | Completed |
| Lion's mane | 6 capsule | Effects of Hericium Erinaceus on Microbiota and Cognition | Cognitive Decline, Mild | 40 | Completed |
| Lion's mane | 60 g | Lifestyle Changes, Mushroom Supplementation, and Bupropion to Reduce Adiposity and Car | Cardiometabolic Syndrome, Obesity and Cardio | 250 | Not yet recruiting |
| Maitake | 10 mg | Study of Grifola Frondosa (Maitake), Azacitidine, and Lenalidomide | Advanced Cancers | 1 | Terminated |
| Maitake | 3 mg/kg | Study of Grifola Frondosa (Maitake), Azacitidine, and Lenalidomide | Advanced Cancers | 1 | Terminated |
| Maitake | 3mg/kg | Does Maitake Mushroom Extract Enhance Hematopoiesis in Myelodysplastic Patients? | Myelodysplastic Syndrome | 45 | Completed |
| Maitake | 75 mg | Study of Grifola Frondosa (Maitake), Azacitidine, and Lenalidomide | Advanced Cancers | 1 | Terminated |
| Mesima | 2 capsule | Sanghuangporus Sanghuang Supplementation to Improve Anti-Fatigue Performance in Health | Nutritional Supplementation, Physical Perfor | 58 | Completed |
| Mesima | 4 capsule | Sanghuangporus Sanghuang Supplementation to Improve Anti-Fatigue Performance in Health | Nutritional Supplementation, Physical Perfor | 58 | Completed |
| Mesima | 4 g | Sanghuangporus Sanghuang Supplementation to Improve Anti-Fatigue Performance in Health | Nutritional Supplementation, Physical Perfor | 58 | Completed |
| Oyster mushroom | 1 mg | Assessing the Efficacy of Micro-dosed Psilocybin on Reducing Anxiety & Depression Leve | Anxiety and Depression | — | Withdrawn |
| Oyster mushroom | 150 mg | Lifestyle Changes, Mushroom Supplementation, and Bupropion to Reduce Adiposity and Car | Cardiometabolic Syndrome, Obesity and Cardio | 250 | Not yet recruiting |
| Oyster mushroom | 18.78g | Neurological, Inflammatory and Metabolic Effects of Acute Mushroom Intervention in Old | Cognitive Change, Mood | 33 | Completed |
| Oyster mushroom | 4.70g | Neurological, Inflammatory and Metabolic Effects of Acute Mushroom Intervention in Old | Cognitive Change, Mood | 33 | Completed |
| Oyster mushroom | 6.67g | Cognitive, Mood, Anti-Inflammatory and Metabolic Effects of Chronic Oyster Mushroom In | Cognitive Change, Mood | 80 | Completed |
| Oyster mushroom | 60 g | Lifestyle Changes, Mushroom Supplementation, and Bupropion to Reduce Adiposity and Car | Cardiometabolic Syndrome, Obesity and Cardio | 250 | Not yet recruiting |
| Oyster mushroom | 7.0 mg | Study Protocol: The Efficacy of Mushroom to Reduce Cognitive Decline in At-Risk Middle | Dementia, Cognitive Assessment | 600 | Recruiting |
| Oyster mushroom | 9.39g | Cognitive, Mood, Anti-Inflammatory and Metabolic Effects of Chronic Oyster Mushroom In | Cognitive Change, Mood | 80 | Completed |
| Oyster mushroom | 9.39g | Neurological, Inflammatory and Metabolic Effects of Acute Mushroom Intervention in Old | Cognitive Change, Mood | 33 | Completed |
| Poria | 0.5mg | Multicenter RCT of Eye-Brain Imaging in Diabetes Neurovascular Coupling | Diabetes Mellitus, Diabetic Retinopathy | 160 | Not yet recruiting |
| Poria | 0.5mg | Defining the Functional Role of Iron in Aerobic Training and Physical Performance | Iron Deficiency Without Anemia | 109 | Completed |
| Poria | 1.0 g | Effect of Chinese Herbal Medicine on Renal Function in Diabetic Kidney Disease | Diabetic Kidney Disease | 66 | Not yet recruiting |
| Poria | 1.0 mg | Exploring the Impact of Nephropathy Formula No. 1 on Chronic Kidney Disease Patients | Renal Insufficiency, Chronic | 70 | Not yet recruiting |
| Poria | 1.5 g | Effect of Chinese Herbal Medicine on Renal Function in Diabetic Kidney Disease | Diabetic Kidney Disease | 66 | Not yet recruiting |
| Poria | 1.5 g | Effect of Chinese Herbal Medicine on Kidney Function in Non-Diabetic CKD | Non-diabetic Chronic Kidney Disease | 66 | Not yet recruiting |
| Poria | 10 g | Evaluating the Effects of Traditional Chinese Medicine by N-of-1 Trials | Bronchiectasis, Quality of Life | 36 | Unknown |
| Poria | 10 g | The Relationship Between XinKang-I and Chronic Heart Failure | Traditional Chinese Medicine | 110 | Unknown |
| Poria | 10 g | Traditional Chinese Medicine Herbs in the Freeze-all IVF Cycle | Infertility, Female | 90 | Unknown |
| Poria | 100 mg | Exploring the Impact of Nephropathy Formula No. 1 on Chronic Kidney Disease Patients | Renal Insufficiency, Chronic | 70 | Not yet recruiting |
| Poria | 100 mg/day | Defining the Functional Role of Iron in Aerobic Training and Physical Performance | Iron Deficiency Without Anemia | 109 | Completed |
| Poria | 10g | RSYR for Fatigue Reduction in Cancer Fatigue Caused by Chemotherapy | Cancer-related Problem/Condition | 196 | Unknown |
| Poria | 10g | A Series of N-of-1 Trials of Traditional Chinese Medicine Based on Bayesian Method | Bronchiectasis, Quality of Life | 71 | Unknown |
| Poria | 10g | Study on the Mechanism of Pei Tu Ning Feng Tang in Alleviating Tourette Syndrome Via F | Tourette Syndrome in Children | 60 | Completed |
| Poria | 10g | Defining the Functional Role of Iron in Aerobic Training and Physical Performance | Iron Deficiency Without Anemia | 109 | Completed |
| Poria | 10g | Serum Metabolomics Study of Traditional Chinese Medicine Formula （Shen Qi Tiao Ti Form | Polycystic Ovary Syndrome | 105 | Unknown |
| Poria | 11mg | Defining the Functional Role of Iron in Aerobic Training and Physical Performance | Iron Deficiency Without Anemia | 109 | Completed |
| Poria | 12 g | Traditional Chinese Medicine Herbs in the Freeze-all IVF Cycle | Infertility, Female | 90 | Unknown |
| Poria | 13.5 g | Effect of Chinese Herbal Medicine on Kidney Function in Non-Diabetic CKD | Non-diabetic Chronic Kidney Disease | 66 | Not yet recruiting |
| Poria | 14.5 g | Effect of Chinese Herbal Medicine on Renal Function in Diabetic Kidney Disease | Diabetic Kidney Disease | 66 | Not yet recruiting |
| Poria | 140 mL | Serum Metabolomics Study of Traditional Chinese Medicine Formula （Shen Qi Tiao Ti Form | Polycystic Ovary Syndrome | 105 | Unknown |
| Poria | 15 g | Evaluating the Effects of Traditional Chinese Medicine by N-of-1 Trials | Bronchiectasis, Quality of Life | 36 | Unknown |
| Poria | 15 g | The Relationship Between XinKang-I and Chronic Heart Failure | Traditional Chinese Medicine | 110 | Unknown |
| Poria | 15 g | Traditional Chinese Medicine Herbs in the Freeze-all IVF Cycle | Infertility, Female | 90 | Unknown |
| Poria | 150ml | Clinical Observation of Qingwei Huazhuo Decoction (Product: Jinsaiyu) in Improving Chi | Precocious Puberty | 94 | Terminated |
| Poria | 15g | A Series of N-of-1 Trials of Traditional Chinese Medicine Based on Bayesian Method | Bronchiectasis, Quality of Life | 71 | Unknown |
| Poria | 15g | Serum Metabolomics Study of Traditional Chinese Medicine Formula （Shen Qi Tiao Ti Form | Polycystic Ovary Syndrome | 105 | Unknown |
| Poria | 15g | Clinical Study on the Prevention and Treatment of Postoperative Metastasis of Lung Can | Lung Cancer | 356 | Unknown |
| Poria | 17g | The Efficacy of Tradition Chinese Medicine in Patients With Irritable Bowel Syndrome | Irritable Bowel Syndrome | 104 | Completed |
| Poria | 2 capsule | Defining the Functional Role of Iron in Aerobic Training and Physical Performance | Iron Deficiency Without Anemia | 109 | Completed |
| Poria | 2.0 g | Effect of Chinese Herbal Medicine on Renal Function in Diabetic Kidney Disease | Diabetic Kidney Disease | 66 | Not yet recruiting |
| Poria | 2.0 g | Effect of Chinese Herbal Medicine on Kidney Function in Non-Diabetic CKD | Non-diabetic Chronic Kidney Disease | 66 | Not yet recruiting |
| Poria | 2.5 g | Effect of Chinese Herbal Medicine on Renal Function in Diabetic Kidney Disease | Diabetic Kidney Disease | 66 | Not yet recruiting |
| Poria | 2.5 g | Effect of Chinese Herbal Medicine on Kidney Function in Non-Diabetic CKD | Non-diabetic Chronic Kidney Disease | 66 | Not yet recruiting |
| Poria | 2.6 g | Exploring the Impact of Nephropathy Formula No. 1 on Chronic Kidney Disease Patients | Renal Insufficiency, Chronic | 70 | Not yet recruiting |
| Poria | 20 g | Evaluating the Effects of Traditional Chinese Medicine by N-of-1 Trials | Bronchiectasis, Quality of Life | 36 | Unknown |
| Poria | 20 g | The Relationship Between XinKang-I and Chronic Heart Failure | Traditional Chinese Medicine | 110 | Unknown |
| Poria | 20 g | Traditional Chinese Medicine Herbs in the Freeze-all IVF Cycle | Infertility, Female | 90 | Unknown |
| Poria | 200 mL per dose | Traditional Chinese Medicine Herbs in the Freeze-all IVF Cycle | Infertility, Female | 90 | Unknown |
| Poria | 20g | RSYR for Fatigue Reduction in Cancer Fatigue Caused by Chemotherapy | Cancer-related Problem/Condition | 196 | Unknown |
| Poria | 20g | A Series of N-of-1 Trials of Traditional Chinese Medicine Based on Bayesian Method | Bronchiectasis, Quality of Life | 71 | Unknown |
| Poria | 20g | Serum Metabolomics Study of Traditional Chinese Medicine Formula （Shen Qi Tiao Ti Form | Polycystic Ovary Syndrome | 105 | Unknown |
| Poria | 250 mL | Study on the Mechanism of Pei Tu Ning Feng Tang in Alleviating Tourette Syndrome Via F | Tourette Syndrome in Children | 60 | Completed |
| Poria | 3.0 g | Effect of Chinese Herbal Medicine on Renal Function in Diabetic Kidney Disease | Diabetic Kidney Disease | 66 | Not yet recruiting |
| Poria | 3.0 g | Effect of Chinese Herbal Medicine on Kidney Function in Non-Diabetic CKD | Non-diabetic Chronic Kidney Disease | 66 | Not yet recruiting |
| Poria | 30 g | Evaluating the Effects of Traditional Chinese Medicine by N-of-1 Trials | Bronchiectasis, Quality of Life | 36 | Unknown |
| Poria | 30 mg | Exploring the Impact of Nephropathy Formula No. 1 on Chronic Kidney Disease Patients | Renal Insufficiency, Chronic | 70 | Not yet recruiting |
| Poria | 300 mL | Study on the Mechanism of Pei Tu Ning Feng Tang in Alleviating Tourette Syndrome Via F | Tourette Syndrome in Children | 60 | Completed |
| Poria | 300ml | Exploring the Impact of Nephropathy Formula No. 1 on Chronic Kidney Disease Patients | Renal Insufficiency, Chronic | 70 | Not yet recruiting |
| Poria | 30g | A Series of N-of-1 Trials of Traditional Chinese Medicine Based on Bayesian Method | Bronchiectasis, Quality of Life | 71 | Unknown |
| Poria | 30g | Serum Metabolomics Study of Traditional Chinese Medicine Formula （Shen Qi Tiao Ti Form | Polycystic Ovary Syndrome | 105 | Unknown |
| Poria | 34g | The Efficacy of Tradition Chinese Medicine in Patients With Irritable Bowel Syndrome | Irritable Bowel Syndrome | 104 | Completed |
| Poria | 3g | RSYR for Fatigue Reduction in Cancer Fatigue Caused by Chemotherapy | Cancer-related Problem/Condition | 196 | Unknown |
| Poria | 5 g | The Relationship Between XinKang-I and Chronic Heart Failure | Traditional Chinese Medicine | 110 | Unknown |
| Poria | 5 mg | Exploring the Impact of Nephropathy Formula No. 1 on Chronic Kidney Disease Patients | Renal Insufficiency, Chronic | 70 | Not yet recruiting |
| Poria | 500 mL | Study on the Mechanism of Pei Tu Ning Feng Tang in Alleviating Tourette Syndrome Via F | Tourette Syndrome in Children | 60 | Completed |
| Poria | 5g | Study on the Mechanism of Pei Tu Ning Feng Tang in Alleviating Tourette Syndrome Via F | Tourette Syndrome in Children | 60 | Completed |
| Poria | 5g | Defining the Functional Role of Iron in Aerobic Training and Physical Performance | Iron Deficiency Without Anemia | 109 | Completed |
| Poria | 6 g | Traditional Chinese Medicine Herbs in the Freeze-all IVF Cycle | Infertility, Female | 90 | Unknown |
| Poria | 6g | RSYR for Fatigue Reduction in Cancer Fatigue Caused by Chemotherapy | Cancer-related Problem/Condition | 196 | Unknown |
| Poria | 8 g | The Relationship Between XinKang-I and Chronic Heart Failure | Traditional Chinese Medicine | 110 | Unknown |
| Poria | 9g | Multicenter RCT of Eye-Brain Imaging in Diabetes Neurovascular Coupling | Diabetes Mellitus, Diabetic Retinopathy | 160 | Not yet recruiting |
| Reishi | 0.8g | Effects of Lingzhi on Disease Progression in Patients With Untreated Early Parkinson's | Parkinson Disease | 288 | Unknown |
| Reishi | 1 g | Safety and Efficacy of Longan and Lingzhi Mushroom Syrup on Immune and Inflammatory Re | Safety Issues | 8 | Completed |
| Reishi | 1.8 g | Mushrooms, Mood and Mental Wellbeing in Gen Z Women | Well-Being, Psychological, Mood | 84 | Completed |
| Reishi | 1.8-g | Mushrooms, Mood and Mental Wellbeing in Gen Z Women | Well-Being, Psychological, Mood | 84 | Completed |
| Reishi | 100 mg | A Clinical Study to Determine if Beta Glucan Reduces the Incidence, Duration or Severi | Upper Respiratory Tract Infections, Mental S | 45 | Unknown |
| Reishi | 100 mg | A Follow-up Trial of Proglucamune® in the Treatment of Protective Qi Deficiency, a TCM | Protective Qi Insufficiency (a Condition Ter | 207 | Completed |
| Reishi | 100 mg | An Evaluation of Proglucamune in the Treatment of Protective Qi Insufficiency | Protective Qi Insufficiency | 30 | Completed |
| Reishi | 100 mg | Effect of HIFAS MENOPAUSE on Quality of Life in Postmenopausal Women | Menopause, Menopausal Symptoms | 20 | Completed |
| Reishi | 1000mg | Phase II Clinical Trial Scheme of Ganoderma Lucidum Spore Powder for Postoperative Che | Osteosarcoma | 80 | Unknown |
| Reishi | 12 mg | Effect of Hifas Intima Oral on Vaginal Microbiota in Healthy Women | Vaginal Microbiota, Microbiota | 30 | Completed |
| Reishi | 120 mg | Vitamin C Plus Cordyceps to Chemotherapy Related Anemia in Pancreatic Cancer | Pancreatic Cancer | 50 | Recruiting |
| Reishi | 1500mg | Clinical Study of Ganoderma Lucidum Spore Combined With Chemotherapy | Carcinoma, Non-Small-Cell Lung | 60 | Unknown |
| Reishi | 180 mg | PsP Ganoderma Lucidum Supplementation and Biomarker Changes in Smokers | Oxidative Stress, Inflammation | 200 | Completed |
| Reishi | 1g | The Effects on Sleep Quality of 1:4 Reishi Liquid Extract | Sleep | 100 | Recruiting |
| Reishi | 2 g/day | Vitamin C Plus Cordyceps to Chemotherapy Related Anemia in Pancreatic Cancer | Pancreatic Cancer | 50 | Recruiting |
| Reishi | 2 g/day | Vitamin C Plus Cordyceps to Quality of Life in Patients With Terminal Stage Pancreatic | Pancreatic Cancer | 50 | Recruiting |
| Reishi | 2 tablet | A Clinical Study to Determine if Beta Glucan Reduces the Incidence, Duration or Severi | Upper Respiratory Tract Infections, Mental S | 45 | Unknown |
| Reishi | 2 tablet | A Follow-up Trial of Proglucamune® in the Treatment of Protective Qi Deficiency, a TCM | Protective Qi Insufficiency (a Condition Ter | 207 | Completed |
| Reishi | 2 tablet | An Evaluation of Proglucamune in the Treatment of Protective Qi Insufficiency | Protective Qi Insufficiency | 30 | Completed |
| Reishi | 2.4 g | Lingzhi and Sen Miao San for the Treatment of Rheumatoid Arthritis | Rheumatoid Arthritis | 70 | Completed |
| Reishi | 2.5 ml | A Study to Evaluate the Effect of Elix Cycle Balance and Daily Harmony on Polycystic O | Polycystic Ovary Syndrome | 70 | Unknown |
| Reishi | 200 mg | Effect of Hifas Intima Oral on Vaginal Microbiota in Healthy Women | Vaginal Microbiota, Microbiota | 30 | Completed |
| Reishi | 240 mg | Effect of HIFAS MENOPAUSE on Quality of Life in Postmenopausal Women | Menopause, Menopausal Symptoms | 20 | Completed |
| Reishi | 250 mg | PsP Ganoderma Lucidum Supplementation and Biomarker Changes in Smokers | Oxidative Stress, Inflammation | 200 | Completed |
| Reishi | 250 mg | Hepatoprotective Effects of Reishi Mushroom- (Ganoderma Lucidum) Among Metabolic Dysfu | Lipid Profile, Liver Biomarkers | 102 | Recruiting |
| Reishi | 280 mg | Effect of HIFAS MENOPAUSE on Quality of Life in Postmenopausal Women | Menopause, Menopausal Symptoms | 20 | Completed |
| Reishi | 2g | Study on the Mechanism of Ganoderma Lucidum Spore Powder in the Treatment of Depressio | Depression, Thyroid Cancer | 298 | Completed |
| Reishi | 3 capsule | Investigating the Effects of Mikei® Red Reishi Essence EX on the Immune System of Pros | Prostate Cancer | — | Withdrawn |
| Reishi | 3 capsule | Lingzhi and Sen Miao San for the Treatment of Rheumatoid Arthritis | Rheumatoid Arthritis | 70 | Completed |
| Reishi | 300 mg | Lingzhi for Cancer Children | Pediatric Cancers | 58 | Completed |
| Reishi | 300 mg/day | Vitamin C Plus Cordyceps to Chemotherapy Related Anemia in Pancreatic Cancer | Pancreatic Cancer | 50 | Recruiting |
| Reishi | 300 mg/day | Vitamin C Plus Cordyceps to Quality of Life in Patients With Terminal Stage Pancreatic | Pancreatic Cancer | 50 | Recruiting |
| Reishi | 300mg | Clinical Study of Ganoderma Lucidum Spore Combined With Chemotherapy | Carcinoma, Non-Small-Cell Lung | 60 | Unknown |
| Reishi | 4.0 g | Lingzhi and Sen Miao San for the Treatment of Rheumatoid Arthritis | Rheumatoid Arthritis | 70 | Completed |
| Reishi | 400mg | Physiological Effects of Nutritional Support in Patients With Parkinson's Disease | Parkinson Disease, Idiopathic Parkinson Dise | 51 | Completed |
| Reishi | 45 mg | Effect of Hifas Intima Oral on Vaginal Microbiota in Healthy Women | Vaginal Microbiota, Microbiota | 30 | Completed |
| Reishi | 490 mg | Investigating the Effects of Mikei® Red Reishi Essence EX on the Immune System of Pros | Prostate Cancer | — | Withdrawn |
| Reishi | 4g/day | Ganoderma Spores Modulate the Gut-Brain Axis | Depression, Thyroid Cancer | 300 | Completed |
| Reishi | 4ml | The Effects on Sleep Quality of 1:4 Reishi Liquid Extract | Sleep | 100 | Recruiting |
| Reishi | 5 tablet | Clinical Study of Ganoderma Lucidum Spore Combined With Chemotherapy | Carcinoma, Non-Small-Cell Lung | 60 | Unknown |
| Reishi | 500mg | Physiological Effects of Nutritional Support in Patients With Parkinson's Disease | Parkinson Disease, Idiopathic Parkinson Dise | 51 | Completed |
| Reishi | 53.33 mg | Effect of Hifas Intima Oral on Vaginal Microbiota in Healthy Women | Vaginal Microbiota, Microbiota | 30 | Completed |
| Reishi | 6 capsule | Investigating the Effects of Mikei® Red Reishi Essence EX on the Immune System of Pros | Prostate Cancer | — | Withdrawn |
| Reishi | 6 capsule | Lingzhi for Cancer Children | Pediatric Cancers | 58 | Completed |
| Reishi | 600mg | Mushrooms, Mood and Mental Wellbeing in Gen Z Women | Well-Being, Psychological, Mood | 84 | Completed |
| Reishi | 8 mg | Effect of Hifas Intima Oral on Vaginal Microbiota in Healthy Women | Vaginal Microbiota, Microbiota | 30 | Completed |
| Reishi | 8-g | Clinical Efficacy of QYHJ and Standard Chemotherapy in the Treatment of Advanced Pancr | Pancreatic Neoplasms | 305 | Completed |
| Reishi | 99 g | Safety and Efficacy of Longan and Lingzhi Mushroom Syrup on Immune and Inflammatory Re | Safety Issues | 8 | Completed |
| Royal sun agaric | 10 g | Effect of Agaricus Blazei (Murrill) ss. Heinemann (Sun Mushroom) | Hepatitis C, Nutritional Status | 10 | Completed |
| Royal sun agaric | 20ml | Agaricus Blazei Murill (ABM) in Patients With Inflammatory Bowel Disease (IBD) | Inflammatory Bowel Disease | 20 | Completed |
| Royal sun agaric | 30 ml | Anti-inflammatory Effect of Agaricus Blazei Murill in Inflammatory Bowel Disease (IBD) | Ulcerative Colitis, Crohn's Disease | 100 | Completed |
| Royal sun agaric | 60 ml | Agaricus Blazei Murill in Patients With Multiple Myeloma | Multiple Myeloma | 39 | Completed |
| Shiitake | 1 g | Enhanced Natural Killer Cell Activity and RBAC | Family Member | 20 | Completed |
| Shiitake | 10 g/day | Evaluation of the Effect of a Shiitake Extract on Lipid Profile in Subjects With Moder | Hypercholesterolemia, Hyperlipidemias | 57 | Completed |
| Shiitake | 100 mg | A Clinical Study to Determine if Beta Glucan Reduces the Incidence, Duration or Severi | Upper Respiratory Tract Infections, Mental S | 45 | Unknown |
| Shiitake | 100 mg | A Follow-up Trial of Proglucamune® in the Treatment of Protective Qi Deficiency, a TCM | Protective Qi Insufficiency (a Condition Ter | 207 | Completed |
| Shiitake | 100 mg | An Evaluation of Proglucamune in the Treatment of Protective Qi Insufficiency | Protective Qi Insufficiency | 30 | Completed |
| Shiitake | 180µg | Response Modifier (Arabinoxylan Rice Bran/MGN-3/Biobran) With Interferon-Alpha for HCV | Hepatitis C, Chronic | 37 | Completed |
| Shiitake | 1g per day | Response Modifier (Arabinoxylan Rice Bran/MGN-3/Biobran) With Interferon-Alpha for HCV | Hepatitis C, Chronic | 37 | Completed |
| Shiitake | 2 tablet | A Clinical Study to Determine if Beta Glucan Reduces the Incidence, Duration or Severi | Upper Respiratory Tract Infections, Mental S | 45 | Unknown |
| Shiitake | 2 tablet | A Follow-up Trial of Proglucamune® in the Treatment of Protective Qi Deficiency, a TCM | Protective Qi Insufficiency (a Condition Ter | 207 | Completed |
| Shiitake | 2 tablet | An Evaluation of Proglucamune in the Treatment of Protective Qi Insufficiency | Protective Qi Insufficiency | 30 | Completed |
| Shiitake | 3 g | Enhanced Natural Killer Cell Activity and RBAC | Family Member | 20 | Completed |
| Shiitake | 3 g | AHCC® as Immune Modulator in Cancer Patients Treated With Immunotherapy | Liver Cancer, Hepatocellular Carcinoma | 94 | Not yet recruiting |
| Shiitake | 3-g | Response Modifier (Arabinoxylan Rice Bran/MGN-3/Biobran) With Interferon-Alpha for HCV | Hepatitis C, Chronic | 37 | Completed |
| Shiitake | 500 mg | Biobran/MGN-3 Increases Innate Resistance and Reduces the Incidence of Influenza-like | Influenza-like Illness | 80 | Completed |
| Tremella | 1200mg | Effects of Tremella Fuciformis on Improvement in Cognitive-Bio-Markers of Cognitive Fu | Healthy Adults With Subjective Memory Compla | 75 | Completed |
| Tremella | 600mg | Effects of Tremella Fuciformis on Improvement in Cognitive-Bio-Markers of Cognitive Fu | Healthy Adults With Subjective Memory Compla | 75 | Completed |
| Turkey tail | 1,200 mg | Effects of Pre-, Pro- & Anti-biotics on Gut Microbiota | Human Gut Microbiota | 32 | Completed |
| Turkey tail | 1.2g | The Thoracic Peri-Operative Integrative Surgical Care Evaluation Trial - Stage III | Lung Cancer, Gastric Cancer | 20 | Recruiting |
| Turkey tail | 1.5g | The Thoracic Peri-Operative Integrative Surgical Care Evaluation Trial - Stage III | Lung Cancer, Gastric Cancer | 20 | Recruiting |
| Turkey tail | 180 mg | PsP Ganoderma Lucidum Supplementation and Biomarker Changes in Smokers | Oxidative Stress, Inflammation | 200 | Completed |
| Turkey tail | 22g | The Thoracic Peri-Operative Integrative Surgical Care Evaluation Trial - Stage III | Lung Cancer, Gastric Cancer | 20 | Recruiting |
| Turkey tail | 24 g | Clinical Trial of Trametes Versicolor in Women With Breast Cancer | Breast Cancer | 11 | Completed |
| Turkey tail | 250 mg | Effects of Pre-, Pro- & Anti-biotics on Gut Microbiota | Human Gut Microbiota | 32 | Completed |
| Turkey tail | 250 mg | PsP Ganoderma Lucidum Supplementation and Biomarker Changes in Smokers | Oxidative Stress, Inflammation | 200 | Completed |
| Turkey tail | 3 g | Clinical Trial of Trametes Versicolor in Women With Breast Cancer | Breast Cancer | 11 | Completed |
| Turkey tail | 3g | The Thoracic Peri-Operative Integrative Surgical Care Evaluation Trial - Stage III | Lung Cancer, Gastric Cancer | 20 | Recruiting |
| Turkey tail | 700 mg | The Thoracic Peri-Operative Integrative Surgical Care Evaluation Trial - Stage III | Lung Cancer, Gastric Cancer | 20 | Recruiting |
| Turkey tail | 8 capsule | RCT of Fomitopsis Officinalis and Trametes Versicolor to Treat COVID-19 | COVID-19 | 54 | Completed |
| Zhu ling | 10 g | Effects of Shenkang Decoction on Creatinine and Blood Urea Nitrogen in Chronic Renal F | Chronic Renal Failure, Hemodialysis | 160 | Completed |
| Zhu ling | 12 g | Effects of Shenkang Decoction on Creatinine and Blood Urea Nitrogen in Chronic Renal F | Chronic Renal Failure, Hemodialysis | 160 | Completed |
| Zhu ling | 15 g | Effects of Shenkang Decoction on Creatinine and Blood Urea Nitrogen in Chronic Renal F | Chronic Renal Failure, Hemodialysis | 160 | Completed |
| Zhu ling | 150 mL | Effects of Shenkang Decoction on Creatinine and Blood Urea Nitrogen in Chronic Renal F | Chronic Renal Failure, Hemodialysis | 160 | Completed |
| Zhu ling | 20 g | Effects of Shenkang Decoction on Creatinine and Blood Urea Nitrogen in Chronic Renal F | Chronic Renal Failure, Hemodialysis | 160 | Completed |
